CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue iScience Année : 2022

CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock

Pierre Tissières

Résumé

Low monocyte (m)HLA-DR expression is associated with mortality in sepsis. G-286A∗rs3087456 polymorphism in promoter III of HLA class II transactivator (CIITA), the master regulator of HLA, has been associated with autoimmune diseases but its role in sepsis has never been demonstrated. In 203 patients in septic shock, GG genotype was associated with 28-day mortality and mHLA-DR remained low whereas it increased in patients with AA or AG genotype. In ex vivo cells, mHLA-DR failed to augment in GG in comparison with AG or AA genotype on exposure to IFN-γ. Promoter III transcript levels were similar in control monocytes regardless of genotype and exposure to IFN-γ. Promoter III activity was decreased in GG genotype in monocyte cell line but restored after stimulation with IFN-γ. Hereby, we demonstrated that G-286A∗rs3087456 significantly impact mHLA-DR expression in patients with septic shock in part through CIITA promoter III activity, that can be rescued using IFN-γ.
Fichier principal
Vignette du fichier
PIIS2589004222015632.pdf (1.84 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification

Dates et versions

hal-04256251 , version 1 (13-11-2023)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Jordi Miatello, Anne-Claire Lukaszewicz, Michael Carter, Valérie Faivre, Stéphane Hua, et al.. CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock. iScience, 2022, 25 (11), pp.105291. ⟨10.1016/j.isci.2022.105291⟩. ⟨hal-04256251⟩
45 Consultations
12 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More